Hamid Kabdy

Hamid Kabdy

Auto-generated profile, based on publicly available information

Hamid Kabdy

Department of Biology, Cadi Ayyad University, Morocco

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025
Verified
Book Chapter
Closed access
JLJawad Laadraoui
Jawad Laadraoui
HKHamid Kabdy
Hamid Kabdy
SOSara Oufquir
Sara Oufquir
MAMehdi Aitlarradia
Mehdi Aitlarradia
FAFatimzahra Agouram
Fatimzahra Agouram
BEBilal EL-MANSOURY
Bilal EL-MANSOURY
Secondary metabolites, bioactive compounds from plants, fungi, and microorganisms, show significant therapeutic potential for neurodegenerative and inflammatory diseases. This chapter highlights their mechanisms of action, including antioxidant activity, modulation of inflammatory pathways, and neuroprotection, supported by preclinical and clinical evidence. Key classes like alkaloids, flavonoids, terpenoids, and polyphenols are explored for their neuroprotective and anti-inflammatory properties, alongside phytochemical sources that emphasize their drug discovery potential. However, challenges such as limited bioavailability, stability, and toxicity hinder their clinical application. Addressing these issues through novel strategies could unlock their full potential in modern medicine. This chapter bridges natural product chemistry and clinical applications, providing insights to inspire further research into secondary metabolites as essential tools for combating complex diseases.

17 June 2025
Verified
Book Chapter
Closed access
JLJawad Laadraoui
Jawad Laadraoui
MAMehdi Aitlarradia
Mehdi Aitlarradia
KOKhadija Oubella
Khadija Oubella
FAFatimzahra Agouram
Fatimzahra Agouram
SOSara Oufquir
Sara Oufquir
BEBilal EL-MANSOURY
Bilal EL-MANSOURY
Behavioral addictions, including gambling, internet/gaming, and food addiction, profoundly affect individuals and society. This chapter examines their neurobiological underpinnings, highlighting dopaminergic pathways, neurotransmitter imbalances, and the neural circuits involved in reward processing and impulse control. It covers diagnostic methods, psychometric tools, and neuroimaging, and reviews treatments such as Cognitive Behavioral Therapy, mindfulness, and pharmacological interventions. Stigma, comorbidities, and relapse risks are addressed, alongside prevention strategies emphasizing education, community support, and regulation. Future directions focus on personalized medicine, genetic and epigenetic research, and digital tools for intervention. By integrating neuroscience, clinical practice, and public health, this chapter offers a comprehensive foundation for understanding and managing behavioral addictions.

7 November 2025
Verified
Book Chapter
Closed access
FBFouad Bouazzaoui
Fouad Bouazzaoui
YJYasmina Jaouhari
Yasmina Jaouhari
OHOuijdane El Hatimy
Ouijdane El Hatimy
HAHajar AZRAIDA
Hajar AZRAIDA
HKHamid Kabdy
Hamid Kabdy
ACAbderrahman Chait
Abderrahman Chait
Neurodegenerative diseases pose a major global health challenge, demanding advanced models and innovative therapeutic strategies. This chapter overviews in vivo, in vitro, and in silico models used to study these disorders and their role in pharmacological and therapeutic research. Such models clarify mechanisms underlying Alzheimer's, Parkinson's, and Huntington's disease while serving as essential platforms for drug testing, toxicity evaluation, and therapy development. A key focus is the integration of nanoparticles, whose small size, large surface area, and ability to cross the blood–brain barrier enable targeted drug delivery with fewer side effects. Functionalization with diagnostic markers further supports early biomarker detection and personalized medicine. By combining experimental models with nanotechnology, this approach improves diagnostic precision and therapeutic efficacy, offering promising prospects for more effective and less invasive treatments of neurodegenerative disorders.

7 November 2025
Verified
Book Chapter
Closed access
HAHajar AZRAIDA
Hajar AZRAIDA
OHOuijdane El Hatimy
Ouijdane El Hatimy
YJYasmina Jaouhari
Yasmina Jaouhari
FBFouad Bouazzaoui
Fouad Bouazzaoui
MBMajda Badaoui
Majda Badaoui
ACAbderrahman Chait
Abderrahman Chait
Neurodegenerative diseases, including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, are increasing, highlighting the need for innovative treatments. Plant-derived phytochemicals, such as flavonoids, alkaloids, terpenoids, and polyphenols, offer neuroprotective properties by reducing oxidative stress, modulating neuroinflammation, preventing neuronal apoptosis, and enhancing neurotrophic signaling and mitochondrial function. However, their clinical application faces challenges like low bioavailability and rapid metabolism. This chapter explores these issues and potential solutions, including advanced drug delivery systems and structural modifications. It also highlights the need for interdisciplinary research to fully harness phytochemicals' therapeutic potential in neurodegenerative disease treatment.

7 November 2025
Verified
Book Chapter
Closed access
HKHamid Kabdy
Hamid Kabdy
Abdelfatah AitbabaAbdelfatah Aitbaba
Abdelfatah Aitbaba
AHAzraida Hajar
Azraida Hajar
JYJaouhari Yasmina
Jaouhari Yasmina
OSOufquir Sara
Oufquir Sara
CAChait Abderrahman
Chait Abderrahman
Neurodegenerative diseases (NDDs) are progressive disorders involving the loss of neuronal structure and function, leading to cognitive, behavioral, and motor decline. With curative therapies lacking, interest has turned to naturally derived compounds with neuroprotective potential. Plant secondary metabolites show anti-inflammatory, antioxidant, and neuroprotective effects, making them promising candidates for NDD management. Cannabis sativa produces cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), along with terpenes and flavonoids, which act on the endocannabinoid system to regulate neuroinflammation, oxidative stress, and neuronal plasticity, showing benefits in multiple sclerosis, epilepsy, anxiety, insomnia, Alzheimer's, and Parkinson's disease. Likewise, constituents of Nicotiana tabacum, including nicotine and related alkaloids, can influence neuroinflammatory pathways and provide neuroprotection at controlled doses. This chapter examines their therapeutic potential, mechanisms, evidence, and translational challenges.